Genta Gets a Second Wind with Its Ganite Drug Genta Incorporated (OTC:GETA) hasn’t been entirely successful in developing its cancer drug Genasense®, but its small molecule program and Ganite® drug candidate could represent promising potential and could represent a second wind for the company! http://sumfolio.com/genta-gets-a-second-wind-with-its-ganite-drug-151/